CL
AZN icon

Choreo LLC’s AstraZeneca AZN Stock Holding History

Choreo LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Sell
20,940
-1,309
-6% -$246K 0.04% 262
2026
Q1 		$4.37M Sell
22,249
-2,972
-12% -$573K 0.05% 238
2025
Q4 		$4.67M Buy
25,221
+1,681
+7% +$295K 0.06% 210
2025
Q3 		$3.61M Buy
23,540
+1,089
+5% +$165K 0.05% 247
2025
Q2 		$3.14M Sell
22,451
-3,514
-14% -$492K 0.04% 265
2025
Q1 		$3.82M Buy
25,965
+777
+3% +$112K 0.06% 221
2024
Q4 		$3.3M Sell
25,188
-833
-3% -$117K 0.05% 244
2024
Q3 		$4.09M Buy
26,021
+2,078
+9% +$335K 0.06% 216
2024
Q2 		$3.73M Buy
23,943
+22,404
+1,456% +$3.37M 0.06% 200
2024
Q1 		$209K Buy
+1,539
New +$204K 0.01% 620
2019
Q3 		– Sell
-2,446
Closed -$202K – 188
2019
Q2 		$202K Sell
2,446
-480
-16% -$37.6K 0.02% 193
2019
Q1 		$237K Sell
2,926
-359
-11% -$28.3K 0.03% 177
2018
Q4 		$249K Sell
3,285
-554
-14% -$43.3K 0.04% 158
2018
Q3 		$304K Hold
3,839
– – 0.04% 165
2018
Q2 		$270K Sell
3,839
-795
-17% -$57.2K 0.04% 200
2018
Q1 		$324K Buy
4,634
+452
+11% +$31.3K 0.04% 203
2017
Q4 		$290K Buy
4,182
+268
+7% +$18.1K 0.04% 225
2017
Q3 		$265K Buy
+3,914
New +$247K 0.03% 229

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Choreo LLC's AZN Position: Q2 2026 in Review

Choreo LLC reduced its AstraZeneca (AZN) stake by 5.9% in Q2 2026, selling an estimated $246K and leaving 20,940 shares worth $3.95M. The position accounts for 0.04% of the portfolio, ranked #262.

Choreo LLC first reported a position in AZN in Q3 2017 and has held it in 18 quarters since. The position peaked at $4.67M in Q4 2025. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Choreo LLC held 20,940 shares of AstraZeneca worth $3.95M as of Q2 2026.
  • Choreo LLC sold 1,309 AstraZeneca shares in Q2 2026, an estimated $246K.
  • AstraZeneca made up 0.04% of Choreo LLC's portfolio in Q2 2026, its #262 holding.
  • Choreo LLC first reported a position in AstraZeneca in Q3 2017 and has held it in 18 quarters since.
  • Choreo LLC's AstraZeneca position peaked at $4.67M in Q4 2025.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.